Divi's Laboratories Reports 49.3% Drop in Q1 Net Profit; Revenue Up 21.2%

14 Aug 2023 , 02:26 PM

Divi’s Laboratories Ltd., a leading pharmaceutical company, announced a 49.3% decline in consolidated net profit for the April-June quarter, with net profit at Rs 356 crore compared to Rs 702 crore last year. 

Revenue from operations, however, increased by 21.2% to Rs 1778 crore from Rs 2255 crore in the previous fiscal. Sequentially, net profit improved by 10.9% from Rs 321 crore in the Jan-Mar quarter of FY23.

Divi’s Laboratories also saw a shift in operational performance, with EBITDA falling 40.6% to Rs 504 crore from Rs 847 crore in the base quarter. The EBITDA margin, or operating profit margin, dropped by 930 basis points to 28.3% in the reported quarter compared to 37.6% in the same quarter last year.

 

For feedback and suggestions, write to us at [e-mail]